MEDVi vs PeterMD: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

52 providers verified independently·Independent research·How we rank →

Visit MEDVi - our pick of these two→or find your match

MEDVi beats PeterMD overall, scoring 7.7/10 vs 7.3/10. PeterMD is more affordable at $165/mo vs $179/mo. Choose MEDVi for users who want a low entry price with oral and injectable co. Choose PeterMD for budget-conscious users looking for the lowest monthly glp-1 .

A side-by-side look at MEDVi and PeterMD to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

Higher Rated

MEDVi

#20 of 52

7.7/10

MEDVi is a compounded GLP-1 telehealth platform offering both oral tablets and injectable semaglutide and tirzepatide, with micro-dosing options for side-effect-sensitive patients. $179/mo entry pricing, free shipping, and a streamlined intake, one of the broader compounded mixes among independent telehealth providers in 2026.

Visit MEDVi

PeterMD

#32 of 52

7.3/10

One of the most affordable compounded GLP-1 options on the market, ideal for budget-conscious patients.

Visit PeterMD

Feature	MEDVi	PeterMD
Our Score	7.7/10	7.3/10
Starting Price	$179/mo	$165/mo
Medication Type	Both	Compounded
Insurance Accepted	No	No
Best For	Users who want a low entry price with oral and injectable compounded options	Budget-conscious users looking for the lowest monthly GLP-1 cost
Ranking	#20	#32
Get started	Visit MEDVi	Visit PeterMD

Pros & Cons Compared

MEDVi

Pros

+One of the few compounded providers offering both oral tablets and injectable semaglutide
+Micro-dosing options available, can start at sub-standard doses for patients concerned about side effects
+Sleek onboarding experience with clear progress tracking through their patient portal
+$179/mo is competitive for a platform with both oral and injectable compounded formulations

Cons

−No brand-name Wegovy or Zepbound on the platform (the 2026 expansion added branded Ozempic only)
−No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms; you can switch to injectable anytime at no extra fee if results lag

PeterMD

Pros

+Flat $165/mo at all dose levels, price doesn't increase as you titrate up to maintenance doses
+100,000+ patient base with 4.9/5 Trustpilot rating from 14,000+ reviews, strong social proof
+Semaglutide + B12 formulation helps reduce nausea, the most common GLP-1 side effect
+Video consultations with physicians included, real face-to-face medical oversight

Cons

−Available in 42 states, not all 50 (8 states are excluded). Check your state during signup before planning around PeterMD.
−Not BBB accredited, and some documented complaints cite delayed medication fulfillment. Order refills ahead of your last dose rather than at the last minute.
−PeterMD began as a testosterone replacement therapy platform; GLP-1 is an expansion, not the original core. The included video consultations give you a direct read on the clinical team.

Our Verdict

MEDVi edges out PeterMD with a score of 7.7/10 vs 7.3/10. If budget is your priority, PeterMD starts at $165/mo compared to MEDVi's $179/mo. MEDVi offers both brand-name and compounded medications, giving you more flexibility. Choose MEDVi if you want: users who want a low entry price with oral and injectable compounded options. Choose PeterMD if you want: budget-conscious users looking for the lowest monthly glp-1 cost.

Still undecided? Editor's Featured Pick

Yucca Health

$146/mo · 7.7/10 · Compounded

If neither MEDVi nor PeterMD feels like the right fit, our featured pick across all 52 GLP-1 telehealth providers is Yucca Health. It is not the highest-scored provider in our full rankings. We feature it for its low-friction value: a flat $146/mo that stays the same at every dose.

Visit Yucca Health→Read our full Yucca Health review